This study aims to develop a non-invasive and rapid diagnostic technology for acute upper gastrointestinal bleeding (AUGIB) by analyzing volatile organic compounds (VOCs) in exhaled breath. Clinically confirmed patients will be divided into three groups (no bleeding, minor bleeding, major bleeding) based on endoscopic findings. VOC profiles will be analyzed to construct a predictive model, validated for sensitivity and specificity (both targets ≥0.7). This approach addresses the limitations of endoscopy in emergency or resource-limited settings, improving diagnostic efficiency and reducing mortality.
Acute upper gastrointestinal bleeding (AUGIB) is a common emergency with an annual incidence of 100-180/100,000 and mortality of 2%-15%. Endoscopy, the gold standard, is invasive and equipment-dependent, limiting its use in primary care or emergencies. Exhaled breath VOCs analysis, a non-invasive and portable method, has been applied in other diseases but not yet explored for AUGIB. Objectives: 1. Identify characteristic VOC profiles in exhaled breath of AUGIB patients. 2. Develop a VOC-based predictive model with sensitivity and specificity ≥0.7. 3. Establish rapid diagnostic criteria to enhance clinical decision-making.
Study Type
OBSERVATIONAL
Enrollment
200
Gastroscopy for all included patients
Using a patient's exhaled breath test with Gas Chromatography - Mass Spectrometry
Sensitivity and specificity of the diagnostic model
targets ≥0.7
Time frame: 4 months
Identification of key VOCs
e.g., aldehydes, ketones
Time frame: 4 months
Differences in VOC concentrations across 3 bleeding severity groups
Different VOCs
Time frame: 4 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.